Diagnostic Test: High-resolution manometry ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 98 | Eosinophilic gastrointestinal disease | 1 |
98. Eosinophilic gastrointestinal disease
Clinical trials : 171 / Drugs : 184 - (DrugBank : 47) / Drug target genes : 42 - Drug target pathways : 141
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04803162 (ClinicalTrials.gov) | November 14, 2017 | 14/3/2021 | The Role of HRM and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected EoE | The Role of High-resolution Esophageal Manometry and Specific Biomarkers of Inflammation in the Diagnosis of Patients With Dysphagia and Suspected Eosinophilic Esophagitis | Eosinophilic Esophagitis | Diagnostic Test: High-resolution manometry;Diagnostic Test: Serum biomarkers;Diagnostic Test: Gastrointestinal Quality of Life index;Drug: Omeprazole 20 MG Oral Tablet | Wroclaw Medical University | NULL | Active, not recruiting | 18 Years | N/A | All | 58 | Poland |